Medical Data Vision Co., Ltd. (TYO:3902)

Medical Data Vision Cash Flow Statement

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-727	1,567	1,426	1,591	1,076
Depreciation & Amortization	127	101	149	135	158
Loss (Gain) From Sale of Assets	4	116	375	1	71
Loss (Gain) From Sale of Investments	127	15	-51	-	-
Loss (Gain) on Equity Investments	514	72	-	-	-
Other Operating Activities	-754	-253	-672	-471	-224
Change in Accounts Receivable	85	-167	-282	-190	-95
Change in Inventory	-16	10	-	24	1
Change in Accounts Payable	82	83	-4	6	26
Change in Other Net Operating Assets	-319	72	-31	-14	-49
Operating Cash Flow	-877	1,616	910	1,082	964
Operating Cash Flow Growth	-	77.58%	-15.90%	12.24%	-19.80%
Capital Expenditures	-154	-30	-53	-24	-26
Cash Acquisitions	-	-	-	-	-108
Sale (Purchase) of Intangibles	-	-	-	-	-1
Investment in Securities	-301	-393	-799	-2	-
Other Investing Activities	-17	-14	-16	-	-7
Investing Cash Flow	-592	-437	-868	-26	-142
Issuance of Common Stock	1	3	-	-	-
Repurchase of Common Stock	-153	-	-871	-889	-589
Common Dividends Paid	-248	-228	-217	-141	-
Other Financing Activities	1	-	109	-	-
Financing Cash Flow	-399	-225	-979	-1,030	-589
Miscellaneous Cash Flow Adjustments	-2	-1	-	-1	-1
Net Cash Flow	-1,870	953	-937	25	232
Free Cash Flow	-1,031	1,586	857	1,058	938
Free Cash Flow Growth	-	85.06%	-19.00%	12.79%	-16.62%
Free Cash Flow Margin	-17.46%	24.71%	14.04%	18.65%	20.48%
Free Cash Flow Per Share	-27.02	41.52	22.41	27.00	23.74
Cash Income Tax Paid	759	258	670	471	224
Levered Free Cash Flow	-712.13	1,593	1,202	1,072	897.25
Unlevered Free Cash Flow	-712.13	1,593	1,202	1,072	897.25
Change in Working Capital	-168	-2	-317	-174	-117

Source: S&P Global Market Intelligence. Standard template. Financial Sources.